Bio-Techne TECH Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's stock-based comp?
- Bio-Techne (TECH) reported stock-based comp of $10.5M in Q1 2026.
- How has Bio-Techne's stock-based comp changed year-over-year?
- Bio-Techne's stock-based comp decreased by 7.9% year-over-year, from $11.39M to $10.5M.
- What is the long-term trend for Bio-Techne's stock-based comp?
- Over 4 years (2021 to 2025), Bio-Techne's stock-based comp has grown at a -4.4% compound annual growth rate (CAGR), from $48.98M to $40.83M.
- What does stock-based comp mean?
- The non-cash cost of paying employees with company stock instead of cash.
- How do you interpret stock-based comp?
- High levels may indicate aggressive talent retention strategies or dilution of shareholder value, while low levels may suggest a more conservative compensation structure.
- How does stock-based comp compare across companies?
- Common in the life sciences and tech sectors; investors monitor this for its impact on earnings quality.